$21.08
+0.08 (+0.38%)
Open$21.00
Previous Close$21.00
Day High$21.96
Day Low$20.40
52W High$36.76
52W Low$5.25
Volume—
Avg Volume28.0K
Market Cap26.58M
P/E Ratio—
EPS$-16.73
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+36.8% upside
Current
$21.08
$21.08
Target
$28.84
$28.84
$22.09
$28.84 avg
$40.88
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.00M | 5.90M | 5.57M |
| Net Income | -817,172 | -706,875 | -767,435 |
| Profit Margin | -13.6% | -12.0% | -13.8% |
| EBITDA | -1,135,758 | -954,399 | -978,652 |
| Free Cash Flow | -597,971 | -436,320 | -559,358 |
| Rev Growth | +2.3% | +18.9% | +16.5% |
| Debt/Equity | 0.18 | 0.16 | 0.22 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |